Skip to search formSkip to main contentSkip to account menu

Dup 937

Known as: Dup-937 
National Institutes of Health

Related topics

Related topics

2 relations
CI 937

Broader (1)

teloxantrone

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1994
1994
Stabilization of an anthrapyrazole antitumour agent, DuP 937, on complexation with heptakis(2,6-di-O-methyl)-beta-cyclodextrin in aqueous solution.
1993
1993
Phase I pharmacokinetic study of DUP-937, a new anthrapyrazole
SummaryDUP-937 is a new anthrapyrazole intercalator that inhibits DNA synthesis. A phase I trial was conducted in which DUP-937… 
1993
1993
Phase II study on DuP 937 (Teloxantrone) in colorectal carcinoma
DuP 937 (Teloxantrone) is a new anthrapyrazole intercalator that inhibits DNA synthesis. Experimental antitumor activity was… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)